The reporting of health systems data use in primary results publications of clinical trials: a systematic review
Reporting of HSD use has improved over time. However, it still does not meet the expectations set out in the CONSORT-ROUTINE extension. Triallists should be encouraged to provide further information in publications about the use of HSD as per the CONSORT-ROUTINE extension guidelines. This would allow greater transparency in reporting, facilitating effective HSD use in future trials.
Authors
- Jemima Thompson (ORCID: https://orcid.org/0000-0002-1853-3599)
- Sharon Love (ORCID: https://orcid.org/0000-0002-6695-5390)
- Marina Bobou (ORCID: https://orcid.org/0000-0002-1875-309X)
- Macey L. Murray (ORCID: https://orcid.org/0000-0001-6418-0854)
- Shiva Taheri (ORCID: https://orcid.org/0000-0003-0879-0601)
- Kate Roberts (ORCID: https://orcid.org/0009-0001-3942-2353)
Institutions
- MRC Clinical Trials Unit at UCL (GB)
- Health Data Research UK (GB)
- University College London (GB)
Publication Details
- Journal
- Trials
- Published
- 2025-11-26
- DOI
- https://doi.org/10.1186/s13063-025-09227-5
- Primary Topic
- Meta-analysis and systematic reviews
- Type
- article
- Field-Weighted Citation Impact
- 0.00